Federal Register #DN 3917

NCI License Opportunity for C816645 Human T-cell Line for Biomedical Research

The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), is offering a license opportunity for a specialized human T-cell line. - Government Buyer: - National Cancer Institute (NCI), Department of Health and Human Services - Technology Transfer Center, National Institutes of Health - OEM Highlight: - NCI is the developer and provider of the C816645 human T-cell line - Product Details: - C816645 Human T-cell Line - Part Number: C816645 - Quantity: Not specified - Description: Human T-cell line transformed by HTLV-1, designed for research on T-cell immortalization, HTLV pathogenesis, and HIV replication; suitable for gene therapy safety assays and replication-competent lentiviral assays - Unique Requirements: - Opportunity is for licensing a fully developed, research-grade cell line - Intended for use in advanced biomedical research and gene therapy safety testing - No service line items or additional products are listed - No specific purchase quantities or delivery requirements provided

Description

The U.S. International Trade Commission has received a complaint entitled Certain Adjustable Child Carriers and Components Thereof, DN 3917. The complaint alleges violations related to the importation, sale for importation, and sale within the United States of certain adjustable child carriers and components. The Commission is soliciting comments on any public interest issues raised by the complaint or complainant's filing pursuant to the Commission's Rules of Practice and Procedure. Comments should address the impact of the requested remedial orders on public health, welfare, competitive conditions, production of like articles, and consumers in the United States.

View original listing